Bempedoic Acid and the Prevention of Cardiovascular Disease
New England Journal of Medicine · 13.04.2023 · 388 (15) · 1427-1430
DOI: 10.1056/nejme2300793 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 13.04.2023. Verfasst von John F Keaney. Beteiligte Einrichtung: From the Division of Cardiovascular Medicine and the Heart and Vascular Center, Brigham and Women's Hospital, and Harvard Medical School - both in Bo…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Hypolipidemic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
This editorial describes the science behind a study of bempedoic acid in persons with or at increased risk for cardiovascular disease who were unable or unwilling to take high-intensity statins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Division of Cardiovascular Medicine and the Heart and Vascular Center, Brigham and Women's Hospital, and Harvard Medical School - both in Boston.
ORCID-Profile: John F Keaney
Zitieren
APA
Keaney, J. F. (2023). Bempedoic Acid and the Prevention of Cardiovascular Disease. New England Journal of Medicine, 388(15), 1427-1430. https://doi.org/10.1056/nejme2300793
Vancouver
Keaney JF. Bempedoic Acid and the Prevention of Cardiovascular Disease. New England Journal of Medicine. 2023;388(15):1427-1430. doi:10.1056/nejme2300793
BibTeX
@article{Keaney2023,
author = {Keaney, John F},
title = {Bempedoic Acid and the Prevention of Cardiovascular Disease},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {15},
pages = {1427--1430},
doi = {10.1056/nejme2300793}
}
EUVIMED